Junling Shen
Overview
Explore the profile of Junling Shen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
277
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dong R, Wang J, Guan R, Sun J, Jin P, Shen J
Antioxidants (Basel)
. 2025 Jan;
14(1).
PMID: 39857438
Breast cancer is one of the most prevalent cancers worldwide. Recent studies have increasingly emphasized the role of oxidative stress in the initiation and progression of breast cancer. This article...
2.
Bai W, Yan C, Yang Y, Sang L, Hao Q, Yao X, et al.
FEBS J
. 2024 Sep;
291(22):4969-4983.
PMID: 39298503
Stromal interaction molecule 1 (STIM1) is the endoplasmic reticulum Ca sensor for store-operated calcium entry and is closely associated with carcinogenesis and tumor progression. Previously, we found that STIM1 is...
3.
Hao Q, Dong R, Bai W, Chang D, Yao X, Zhang Y, et al.
Biophys Rep
. 2024 May;
10(1):15-21.
PMID: 38737474
Tumor metastasis, responsible for approximately 90% of cancer-associated mortality, remains poorly understood. Here in this study, we employed a melanoma lung metastasis model to screen for metastasis-related genes. By sequential...
4.
Sang L, Wang X, Bai W, Shen J, Zeng Y, Sun J
Front Oncol
. 2022 Oct;
12:1011230.
PMID: 36249028
Hepatocyte Nuclear Factor 4 Alpha (HNF4α) is a master transcription factor mainly expressed in the liver, kidney, intestine and endocrine pancreas. It regulates multiple target genes involved in embryonic development...
5.
Shen J, Yang J, Sang L, Sun R, Bai W, Wang C, et al.
Cancer Biol Med
. 2021 Sep;
19(8).
PMID: 34570440
Objective: The BRAF inhibitor, vemurafenib, has been widely used in the treatment of patients with melanoma-bearing BRAF mutations. While the initial response to vemurafenib is usually excellent, the majority of...
6.
Jia D, Li Z, Dang Q, Shang L, Shen J, Leng X, et al.
J Agric Food Chem
. 2020 Mar;
68(15):4292-4304.
PMID: 32207980
The color of apple skin, particularly anthocyanin-based coloration, is a key factor determining market acceptance. The mechanisms of anthocyanin accumulation in apples with different skin color patterns (i.e., striped and...
7.
Ren Z, Li J, Shen J, Yu H, Mei X, Zhao P, et al.
Pharm Biol
. 2020 Jan;
58(1):116-123.
PMID: 31967915
Clinical reports showed sildenafil beneficial therapy on severe chronic obstructive pulmonary disease (COPD) with pulmonary hypertension (PH) patients. The study investigated therapeutic effects of silenafil on pulmonary damage induced by...
8.
Sun Y, Huang C, Shen J, Zhong Y, Ning J, Hu Y
J Colloid Interface Sci
. 2019 Oct;
558:1-8.
PMID: 31580951
Sluggish water dissociation kinetics in the Volmer step is still the huge challenge in designing and synthesizing transition-metal-based electrocatalysts for hydrogen evolution reaction (HER) in alkaline media. Herein, we report...
9.
Lu W, Shen J, Zhang P, Zhong Y, Hu Y, Lou X
Angew Chem Int Ed Engl
. 2019 Aug;
58(43):15441-15447.
PMID: 31380596
Hierarchical hollow structures for electrode materials of supercapacitors could enlarge the surface area, accelerate the transport of ions and electrons, and accommodate volume expansion during cycling. Besides, construction of heterostructures...
10.
Xu C, Li Q, Shen J, Yuan Z, Ning J, Zhong Y, et al.
Nanoscale
. 2019 May;
11(22):10738-10745.
PMID: 31120471
Transition metal-based nanostructures have been considered as promising substitutes for rare-earth metal oxide electrocatalysts toward the oxygen evolution reaction (OER). Herein, we report for the first time on a novel...